
Adipose-PRP Ovarian Rejuvenation
If you were told that you have no eggs (because you have menopause or POI) or your eggs are bad quality because you are older than 45, Adipose-PRP Ovarian Rejuvenation could help you have babies using your own eggs and avoid Donor Eggs.
A groundbreaking technology highlights live births in women over 45
-
Adipose-PRP ovarian rejuvenation is an advanced, research-driven fertility approach that combines platelet-rich plasma (PRP) with regenerative stem cells derived from a patient's own adipose (fat) tissue.
-
RFC is the First in the World to publish about live birth in women over 45 using Adipose-PRP Ovarian Rejuvenation.
Who is Adipose-PRP ovarian rejuvenation for?
1. Women between ages of 40-53 with very low AMH (<1.0)
Have very low AMH (even if your AMH is ZERO) or diminished ovarian reserve (DOR) and wish to pursue pregnancy using their own eggs
2. Women younger than 40 with poor ovarian response
Have had a poor ovarian response to prior IVF cycles
3. Egg or embryo quality concerns
Have concerns regarding egg or embryo quality
4. Premature ovarian insufficiency (POI) or Menopause
Have POI or early menopause
5. Structured, monitored plan
Want a structured, closely monitored plan guided by an experienced, research-focused fertility team

What Makes It Different?
Unlike standard PRP (platelets only), Adipose-PRP includes stem cells with enhanced regenerative potential. Dr. Merhi has pioneered this technique and published research on ovarian rejuvenation.
Why choose RFC for Adipose-PRP ovarian rejuvenation?
Rejuvenating Fertility Center is a global leader in ovarian rejuvenation:
-
The FIRST in the Northeast to pioneer PRP ovarian rejuvenation and report babies in women over 40
-
The FIRST IN THE WORLD to offer Adipose-PRP ovarian rejuvenation and report babies in women over 45
-
Leaders in treating women with diminished ovarian reserve (DOR)
-
Multiple peer-reviewed publications on PRP and Adipose-PRP ovarian rejuvenation
-
Care for patients nationwide and internationally
-
A philosophy focused on restoring function first and tailoring IVF only when appropriate
American Journal of Stem Cells, 2025;14(5)
RFC published the first documented live births in the world following intra-ovarian administration of adipose-derived stem cells combined with PRP in women aged 45 and older.
Publication: First live births after adipose-derived stem cells and platelet-rich plasma intraovarian administration
This report describes successful pregnancies in women over 45 using adipose-PRP ovarian rejuvenation following prior infertility and failed IVF attempts.
What is Adipose-PRP ovarian rejuvenation?
Adipose-PRP ovarian rejuvenation combines two autologous biologic components:
Platelet-Rich Plasma (PRP)
Derived from your blood
+
Adipose-derived regenerative cells
Obtained from a small fat sample from your belly
The goal is to support the ovarian environment using biologic signals that may help improve ovarian function and response in appropriately selected patients. This approach is often considered when a patient desires a more intensive regenerative strategy than PRP alone.
This treatment is not about adding eggs. Instead, it is designed to support ovarian function and responsiveness—how each patient responds can vary significantly.

Why adipose (fat)?
RFC uses adipose tissue because it is:
-
Easily accessible through a small, minimally invasive mini-liposuction
-
A well-studied source of regenerative cells in human medicine
-
Autologous (from the patient's own body), reducing immunogenic risk
Adipose-containing regenerative stem cells are combined with PRP to create a biologic environment intended to support ovarian function.
How the Adipose-PRP procedure is performed
PRP preparation (≈40 minutes)
Blood is drawn from the arm and processed to prepare platelet-rich plasma.
Mini liposuction (≈30 minutes)
A small amount of fat is gently collected from the abdomen through a tiny entry point (usually <1 cm). Regenerative cells are extracted from the adipose tissue.
Combination + delivery (≈20 minutes)
The adipose-derived regenerative component is combined with PRP and injected intra-ovarianly under ultrasound guidance (and in select cases, intra-uterine), with anesthesia and comfort measures provided.
Most patients spend approximately 2 hours at the clinic.


What happens after Adipose-PRP?
After the procedure, patients typically undergo weekly monitoring for 2–8 weeks, including:
-
Hormone testing
-
Vaginal ultrasound with follicle tracking
-
It might take few months in certain cases to see any improvement
If ovarian response improves, your physician may recommend timing fertility treatment, such as IVF, based on individualized findings.
Frequently asked questions
How do I know if I need Adipose-PRP instead of standard PRP ovarian rejuvenation?
Standard PRP is typically the first-line approach. Your doctor may recommend upgrading to Adipose-PRP if you are over 45, if your AMH is extremely low or zero, if you've already tried standard PRP without adequate response, or if you've had multiple failed IVF cycles with poor egg quality. Adipose-PRP adds fat-derived stem cells to create a stronger regenerative signal — it's designed for cases where platelets alone may not be enough. Your physician at RFC will assess your history and recommend the right starting point.
Is Adipose-PRP ovarian rejuvenation FDA approved?
No. Adipose-PRP ovarian rejuvenation is not FDA approved as a fertility treatment. It is an autologous procedure using your own blood and fat tissue, which falls under the practice of medicine rather than drug or device regulation. PRP and adipose stem cell therapies are used across many medical fields under this same framework. While published evidence — including the first documented live births in women over 45 — is encouraging, larger randomized controlled trials are still ongoing. RFC provides full informed consent and transparent counseling before any procedure.
I tried PRP ovarian rejuvenation at another clinic and it didn't work. Should I try Adipose-PRP?
A failed PRP at another clinic does not mean regenerative treatment won't work for you. PRP outcomes depend heavily on platelet concentration, injection technique, needle size, injection sites, and post-procedure protocol — all of which vary between providers. Adipose-PRP adds fat-derived stem cells that provide a stronger biological stimulus than PRP alone. RFC will review your prior treatment details, current hormone levels, and IVF history to determine whether Adipose-PRP is the right next step or whether other options should be explored.
How long do the effects of Adipose-PRP last, and when should I start IVF after?
Adipose-PRP may produce a longer response window than standard PRP due to the regenerative potential of fat-derived stem cells, but exact duration varies by individual. Because the effects are temporary and ovarian aging continues, patients who show improvement are encouraged to proceed with IVF, egg freezing, or natural conception without delay. Your physician will use weekly monitoring to identify the optimal timing for treatment — waiting too long risks losing the response window.
Will the mini-liposuction leave a scar or require recovery time?
The mini-liposuction used in Adipose-PRP is very small — fat is collected through a tiny abdominal entry point, typically less than 1 cm. Most patients have no visible scarring once healed. Recovery is quick: mild soreness at the collection site for 1 to 2 days, and most patients return to normal activities within 24 to 48 hours. The procedure is performed under anesthesia with comfort measures and takes approximately 30 minutes as part of the overall 2-hour appointment.
Can I get pregnant naturally after Adipose-PRP, or do I need IVF?
Some patients may be able to conceive naturally after Adipose-PRP if ovarian function improves, the fallopian tubes are open, and there are no significant male fertility factors. However, most patients — especially those over 40 or with severely diminished ovarian reserve — are advised to pursue IVF or egg freezing to maximize the response window. RFC offers three types of IVF, including natural and mini approaches, and does not recommend aggressive high-dose stimulation after rejuvenation. Your physician will guide the best path based on your monitoring results.
OVARIAN REJUVENATION SUCCESS RATES AND RESEARCH FROM RFC:
-
Zaher Merhi. Clinical practice perspectives on adipose-derived stem cells and platelet-rich plasma for female infertility treatments. Future Sci OA. 2025 Dec;11(1):2580233.
-
Zaher Merhi, Bhavika Garg, Jessica Haroun. Endocrine and regenerative mechanisms of adipose-derived stem cells in female infertility. Front Endocrinol (Lausanne). 2025 Oct 21:16:1694025
-
Zaher Merhi and Marco Mouanness. Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization. Clin Exp Reprod Med. 2022;49:210-214.
- Zaher Merhi and Marco Mouanness. Intraovarian Platelet-Rich Plasma administration Induced Spontaneous Ovulation in an Anovulatory Woman with PCOS. JCEM Case Reports. 2023;21;1:38.
-
Zaher Merhi and Marco Mouanness. Intraovarian PRP Injection Improved Hot Flashes in a Woman With Very Low Ovarian Reserve. Reprod Sci. 2022;29:614-619.
-
Marco Mouanness and Zaher Merhi and. Use of Intra-uterine Injection of Platelet-rich Plasma (PRP) for Endometrial Receptivity and Thickness: a Literature Review of the Mechanisms of Action. Reprod Sci. 2021;28:1659-1670.
-
Zaher Merhi and Marco Mouanness. Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action. J Assist Reprod Genet. 2022;39:37-61.
-
Zaher Merhi, Catrina Wiltshire McLeod, Fawziyah Shamim. Platelet-Rich Plasma in Reproductive Endocrinology: Mechanisms and Clinical Applications for Ovarian Reserve, PCOS, and Endometrial Receptivity. Biomedicines. 2025 Oct 13;13(10):2488.
